All In MedTech

Device Trial Radar · NCT03066505

A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With ADHD

A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With Attention Deficit Hyperactivity Disorder.

Last checked: Nov 19, 2026Latest source record: Apr 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Feb 23, 2016

Primary completion

Apr 17, 2019

Study completion Apr 17, 2019

Sponsor

Lead sponsor
Wave NeuroscienceNot on our public-company list
Sponsor type
Industry
First posted
Feb 28, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot study is a randomized, double-blind, sham-controlled study designed to evaluate the efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in college students with ADHD. A total of 40 subjects will be treated.

Conditions

  • ADHD

Interventions

  • Active MeRT TreatmentDevice

    A personalized biometrics-guided protocol known as magnetic EEG/EKG resonance therapy (MeRT) treatment that is tailored specifically to each patient's higher harmonic frequency of heart rate, which is nearest to the characteristic frequency of alpha EEG frequency.

  • Sham MeRT TreatmentDevice

    A personalized biometrics-guided protocol similar to MeRT treatment that mimics magnetic EEG/EKG resonance therapy (MeRT) but does not emit active stimulation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pearson Quotient ADHD SystemTime frame: Four weeks.
  2. Conners Adult ADHD Rating Scales (CAARS)Time frame: Four weeks.
  3. Electroencephalogram (EEG) AssessmentTime frame: Four weeks.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • USC Neurorestoration Center

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.